Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of LX1606 in Subjects With Symptomatic Carcinoid Syndrome

This study has been completed.
Information provided by (Responsible Party):
Lexicon Pharmaceuticals Identifier:
First received: April 12, 2010
Last updated: April 1, 2016
Last verified: April 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: February 2014 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: February 4, 2016